0,863  0,004  Caspase 9 stimulant
0,812  0,004  Tubulin antagonist
0,793  0,004  Aldehyde oxidase inhibitor
0,759  0,004  UGT1A9 substrate
0,754  0,014  Antineoplastic (breast cancer)
0,745  0,011  Antineoplastic (colorectal cancer)
0,741  0,010  Antineoplastic (colon cancer)
0,721  0,016  Antineoplastic (lung cancer)
0,698  0,004  Genotoxic
0,693  0,005  UGT1A6 substrate
0,697  0,010  Prostate cancer treatment
0,692  0,008  5 Hydroxytryptamine release stimulant
0,677  0,003  Alpha tubulin antagonist
0,667  0,004  UGT1A3 substrate
0,671  0,016  TNF expression inhibitor
0,660  0,008  NOS2 expression inhibitor
0,684  0,033  Apoptosis agonist
0,653  0,009  CTGF expression inhibitor
0,646  0,008  Antineoplastic (non-small cell lung cancer)
0,637  0,003  Beta tubulin antagonist
0,630  0,011  Antineoplastic (cervical cancer)
0,615  0,007  Antimitotic
0,604  0,011  Cardiovascular analeptic
0,602  0,015  Antineoplastic (ovarian cancer)
0,585  0,004  UGT2B4 substrate
0,586  0,014  Antineoplastic (melanoma)
0,574  0,008  Antimutagenic
0,583  0,026  Antileukemic
0,559  0,003  Tyrosine 3 hydroxylase inhibitor
0,587  0,033  Transcription factor NF kappa B inhibitor
0,573  0,024  CYP2C9 substrate
0,555  0,015  Antioxidant
0,554  0,015  Cytostatic
0,550  0,015  AR expression inhibitor
0,537  0,015  Caspase 3 stimulant
0,531  0,013  Free radical scavenger
0,522  0,011  UDP-glucuronosyltransferase substrate
0,513  0,004  UGT2B15 substrate
0,513  0,004  Pneumotoxic
0,540  0,033  15-Lipoxygenase inhibitor
0,518  0,013  CYP1A2 inhibitor
0,543  0,038  Antineoplastic (solid tumors)
0,513  0,008  UGT1A4 substrate
0,517  0,016  Antineoplastic (glioma)
0,499  0,005  Calcium channel activator
0,508  0,014  Hypoxia-inducible factor 1 alpha inhibitor
0,503  0,014  Antineoplastic (glioblastoma multiforme)
0,514  0,025  CYP2C19 substrate
0,524  0,037  CYP3A4 substrate
0,492  0,014  Superoxide dismutase inhibitor
0,485  0,007  Antineoplastic (squamous cell carcinoma)
0,487  0,011  UGT1A1 substrate
0,491  0,023  Cardioprotectant
0,482  0,016  Amyloid beta aggregation inhibitor
0,461  0,009  Cyclic AMP phosphodiesterase inhibitor
0,479  0,029  Antihypercholesterolemic
0,473  0,024  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,469  0,022  Chemopreventive
0,473  0,027  CYP1A2 substrate
0,477  0,033  Vasodilator, peripheral
0,461  0,018  Cardiodepressant
0,476  0,038  Histamine release inhibitor
0,442  0,007  Sulfotransferase substrate
0,476  0,041  5 Hydroxytryptamine release inhibitor
0,447  0,015  Peroxidase inhibitor
0,461  0,034  Ulceration
0,461  0,036  CYP2C19 inhibitor
0,450  0,026  Lipoxygenase inhibitor
0,461  0,045  Antipruritic, allergic
0,425  0,009  GST M1-1 substrate
0,424  0,008  Amylase inhibitor
0,436  0,021  DNA damaging
0,446  0,032  Spasmolytic
0,438  0,026  Antineoplastic (multiple myeloma)
0,441  0,030  12-Lipoxygenase inhibitor
0,412  0,005  Cystathionine beta-synthase inhibitor
0,454  0,051  GST A substrate
0,414  0,012  Antineoplastic (carcinoma)
0,438  0,038  Respiratory analeptic
0,412  0,014  Abortion inducer
0,446  0,053  Calcium channel L-type activator
0,426  0,033  Antineoplastic (brain cancer)
0,413  0,021  Antineoplastic (renal cancer)
0,406  0,015  P-glycoprotein inhibitor
0,401  0,015  Antineoplastic (sarcoma)
0,408  0,026  Tumour necrosis factor alpha release inhibitor
0,414  0,035  Antineoplastic (pancreatic cancer)
0,383  0,005  Dopamine agonist
0,406  0,028  Proliferative diseases treatment
0,386  0,009  Antineoplastic (gastric cancer)
0,387  0,014  Antiseptic
0,378  0,007  Neurotrophic factor enhancer
0,389  0,019  RNA-directed DNA polymerase inhibitor
0,390  0,020  Sodium/bile acid cotransporter inhibitor
0,380  0,014  UGT2B7 substrate
0,369  0,004  Dopamine D2 agonist
0,375  0,012  VCAM1 expression inhibitor
0,397  0,035  Chemoprotective
0,397  0,036  Cytotoxic
0,364  0,005  Dopamine D1 antagonist
0,382  0,025  Antineoplastic (osteosarcoma)
0,405  0,048  Cholesterol antagonist
0,367  0,012  Topoisomerase II inhibitor
0,403  0,048  Bone diseases treatment
0,376  0,023  Antineoplastic (lymphocytic leukemia)
0,388  0,034  Sensitization
0,385  0,032  Mutagenic
0,371  0,019  Antineoplastic (bladder cancer)
0,353  0,003  UGT2B10 substrate
0,358  0,019  Non-steroidal antiinflammatory agent
0,366  0,029  Pyruvate kinase inhibitor
0,382  0,046  Teratogen
0,343  0,007  UGT2B1 substrate
0,377  0,043  Vasodilator, coronary
0,375  0,043  Antiosteoporotic
0,336  0,004  SULT1A1 substrate
0,366  0,035  Antipyretic
0,342  0,014  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,364  0,036  Antiamyloidogenic
0,376  0,049  CYP2D6 substrate
0,357  0,031  Vasodilator
0,353  0,028  Antihypertriglyceridemic
0,351  0,025  5 Hydroxytryptamine uptake stimulant
0,350  0,027  Antineoplastic enhancer
0,332  0,011  CYP2B6 inhibitor
0,356  0,039  Radiosensitizer
0,320  0,005  Estrogen receptor beta antagonist
0,338  0,026  Anesthetic general
0,344  0,033  Nitric oxide antagonist
0,316  0,005  Estrogen antagonist
0,360  0,050  NOS3 expression inhibitor
0,357  0,049  Analeptic
0,339  0,032  Sigma receptor agonist
0,320  0,015  NOS3 expression enhancer
0,324  0,019  Melanin inhibitor
0,322  0,019  DNA methyltransferase I inhibitor
0,312  0,012  Glutathione S-transferase substrate
0,338  0,041  Antineoplastic (small cell lung cancer)
0,306  0,010  Carcinogenic, group 1
0,305  0,009  SULT1A3 substrate
0,318  0,025  Antihypotensive
0,297  0,005  Estrogen agonist
0,317  0,025  Hepatoprotectant
0,315  0,024  DNA methylase inhibitor
0,349  0,060  Hepatic disorders treatment
0,327  0,041  Transcription factor STAT3 inhibitor
0,336  0,052  Embryotoxic
0,306  0,030  Muscle relaxant
0,293  0,020  Lipid peroxidase inhibitor
0,292  0,021  Skin whitener
0,277  0,007  VEGF expression inhibitor
0,336  0,069  ICAM1 expression inhibitor
0,282  0,015  NADPH oxidase inhibitor
0,280  0,014  Succinate dehydrogenase inhibitor
0,274  0,010  Expectorant
0,264  0,004  Prolactin inhibitor
0,313  0,056  FMO3 substrate
0,380  0,123  Alpha-glucosidase inhibitor
0,265  0,009  Topoisomerase II alpha inhibitor
0,272  0,017  Acetylcholinesterase inhibitor
0,272  0,017  M18 aspartyl aminopeptidase inhibitor
0,299  0,045  Carcinogenic
0,268  0,014  Topoisomerase I inhibitor
0,326  0,073  FMO1 substrate
0,303  0,050  Antineoplastic (lymphoma)
0,267  0,015  LDLR expression enhancer
0,256  0,004  Dopamine D5 antagonist
0,255  0,004  Estradiol 17 beta-dehydrogenase inhibitor
0,304  0,053  Transcription factor STAT inhibitor
0,266  0,016  Heat shock protein 90 antagonist
0,338  0,088  CYP2C9 inhibitor
0,392  0,144  Antiinflammatory
0,339  0,092  GABA C receptor rho-3 antagonist
0,253  0,009  Toll-Like receptor 2 antagonist
0,285  0,041  5 Hydroxytryptamine 1E antagonist
0,266  0,026  Tumour necrosis factor antagonist
0,260  0,020  GST P1-1 substrate
0,317  0,078  Antithrombotic
0,256  0,019  UGT2B9 substrate
0,292  0,055  Antineoplastic (liver cancer)
0,240  0,003  Topoisomerase II beta inhibitor
0,237  0,008  Protein kinase C zeta inhibitor
0,244  0,015  Alpha 2b adrenoreceptor antagonist
0,284  0,059  Antiprotozoal (Leishmania)
0,245  0,021  Antineoplastic (bone cancer)
0,229  0,006  Keratolytic
0,250  0,028  Interferon gamma antagonist
0,226  0,004  DOPA decarboxylase inhibitor
0,228  0,007  Estrogen receptor alpha antagonist
0,235  0,014  Endometrios treatment
0,224  0,010  Coagulant
0,243  0,030  Skeletal muscle relaxant
0,228  0,018  Mannose-6-phosphate isomerase inhibitor
0,294  0,084  Antineoplastic (endocrine cancer)
0,215  0,005  CDC25A inhibitor
0,246  0,037  Antipruritic, non-allergic
0,216  0,008  Antineoplastic (uterine cancer)
0,216  0,008  Creatine kinase inhibitor
0,210  0,004  UGT2B11 substrate
0,216  0,010  Antihelmintic (Trematoda)
0,236  0,032  Heat shock protein 90 alpha antagonist
0,222  0,021  Alkylator
0,239  0,040  Nitric-oxide synthase stimulant
0,213  0,014  Carbonic anhydrase III inhibitor
0,209  0,010  Adenylate cyclase stimulant
0,202  0,004  Estrogen receptor alpha agonist
0,206  0,009  NAD(P)H dehydrogenase (quinone) inhibitor
0,216  0,019  Arachidonic acid antagonist
0,210  0,013  Alpha 2a adrenoreceptor antagonist
0,267  0,071  Flavin-containing monooxygenase substrate
0,211  0,016  Alpha 2 adrenoreceptor antagonist
0,227  0,035  Contraceptive
0,242  0,050  Antialcoholic
0,216  0,025  Phobic disorders treatment
0,204  0,013  Protein kinase C gamma inhibitor
0,222  0,031  Antidote
0,303  0,113  Immunosuppressant
0,287  0,100  Angiogenesis inhibitor
0,216  0,029  Monophenol monooxygenase inhibitor
0,240  0,054  Sedative
0,232  0,045  Insulin sensitizer
0,190  0,005  Antifungal (Pneumocystis)
0,213  0,027  Antifungal enhancer
0,291  0,106  Prostaglandin dehydrogenase inhibitor
0,256  0,071  Antidiabetic symptomatic
0,225  0,043  Lipocortins synthesis antagonist
0,239  0,057  Platelet aggregation inhibitor
0,205  0,023  5-Lipoxygenase inhibitor
0,191  0,010  HIV-1 integrase (Strand Transfer) inhibitor
0,204  0,024  Antitussive
0,210  0,031  Uterine stimulant
0,196  0,019  Alpha 2c adrenoreceptor antagonist
0,204  0,027  GABA C receptor rho-2 antagonist
0,194  0,018  Choleretic
0,214  0,041  Cholinergic
0,189  0,016  Contraceptive female
0,185  0,014  Histidine decarboxylase inhibitor
0,258  0,088  Radioprotector
0,191  0,022  Microtubule formation inhibitor
0,172  0,002  Dopamine D5 agonist
0,173  0,004  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,180  0,011  HIV-1 integrase (3'-Processing) inhibitor
0,184  0,017  Photosensitizer
0,206  0,041  Antiparkinsonian, tremor relieving
0,239  0,074  DNA synthesis inhibitor
0,180  0,016  Breast cancer-resistant protein inhibitor
0,173  0,010  Postmenopausal disorders treatment
0,185  0,023  Xanthine oxidase inhibitor
0,202  0,041  Aldehyde oxidase substrate
0,201  0,041  Protein kinase stimulant
0,175  0,016  Carbonic anhydrase VI inhibitor
0,196  0,038  Carcinogenic, group 3
0,187  0,030  Cholesterol synthesis inhibitor
0,168  0,011  SULT1E1 substrate
0,187  0,030  Gout treatment
0,268  0,111  Apoptosis antagonist
0,199  0,043  Toxic, respiratory center
0,188  0,032  MAO A inhibitor
0,173  0,018  Carbonic anhydrase XIII inhibitor
0,165  0,010  Acetylcholine release stimulant
0,204  0,050  3C-like protease (Human coronavirus) inhibitor
0,193  0,039  Neurotensin receptor agonist
0,192  0,039  Catenin beta inhibitor
0,223  0,070  Antiparkinsonian, rigidity relieving
0,160  0,006  Estrogen receptor beta agonist
0,237  0,084  Vascular (periferal) disease treatment
0,180  0,027  MAP3K9 inhibitor
0,173  0,021  Antineoplastic alkaloid
0,190  0,038  Bone formation stimulant
0,179  0,029  Antihemorrhagic
0,167  0,019  AMP-activated protein kinase stimulant
0,213  0,066  Antiviral (Influenza)
0,151  0,005  Granulocyte macrophage colony stimulating factor agonist
0,226  0,081  Angiogenesis stimulant
0,156  0,015  Anabolic
0,175  0,034  DNA intercalator
0,286  0,146  Antibacterial
0,145  0,005  Heat shock protein 90 beta antagonist
0,152  0,013  Aromatase inhibitor
0,242  0,104  Insulysin inhibitor
0,162  0,025  Heat shock protein 70 antagonist
0,183  0,047  Hexokinase inhibitor
0,198  0,062  Dual specificity phosphatase 3 inhibitor
0,169  0,033  Alpha adrenoreceptor antagonist
0,241  0,107  Antihypoxic
0,175  0,041  CF transmembrane conductance regulator agonist
0,286  0,152  Antiparkinsonian
0,155  0,021  Arylamine N-Acetyltransferase substrate
0,140  0,008  SULT1A2 substrate
0,188  0,056  Eye irritation, high
0,151  0,019  Phosphodiesterase 4D inhibitor
0,158  0,027  Ca2+-transporting ATPase inhibitor
0,160  0,028  Bronchodilator
0,149  0,021  Electron transport complex I inhibitor
0,157  0,029  Mucolytic
0,198  0,072  Histone acetyltransferase inhibitor
0,131  0,006  Estrogen-related receptor beta agonist
0,150  0,026  Protein kinase C mu inhibitor
0,220  0,096  Hypoglycemic
0,133  0,009  Narcotic antagonist
0,153  0,031  NAT2 substrate
0,147  0,027  Multidrug resistance-associated protein 1 inhibitor
0,175  0,056  Hair growth stimulant
0,154  0,035  Excitatory amino acid transporter EAAC1 inhibitor
0,152  0,035  Antiadrenergic
0,129  0,012  HIV-1 integrase inhibitor
0,119  0,005  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,168  0,054  Antidiarrheal
0,118  0,004  SULT2A1 substrate
0,152  0,038  Carcinogenic, group 2B
0,151  0,037  Gastritis treatment
0,157  0,044  Interleukin 4 antagonist
0,130  0,018  Restless leg syndrome treatment
0,146  0,036  Adrenaline antagonist
0,172  0,061  Protein-tyrosine phosphatase inhibitor
0,143  0,034  Antiviral (Influenza B)
0,154  0,045  Cyclooxygenase 3 inhibitor
0,138  0,029  Toll-Like receptor 4 antagonist
0,158  0,050  Psychosexual dysfunction treatment
0,112  0,004  Postcoital contraceptive
0,147  0,041  Vanilloid 1 agonist
0,127  0,020  Alpha adrenoreceptor agonist
0,134  0,029  Dopamine antagonist
0,133  0,028  Carcinogenic, group 2A
0,171  0,067  Muscular dystrophy treatment
0,174  0,071  Dual specificity phosphatase inhibitor
0,126  0,023  Macrophage migration inhibitory factor inhibitor
0,135  0,034  Beta glucuronidase inhibitor
0,139  0,038  Butyrylcholinesterase inhibitor
0,247  0,146  Stroke treatment
0,175  0,075  Antirickettsial
0,134  0,034  Chronic obstructive bronchitis treatment
0,170  0,070  ATPase inhibitor
0,157  0,057  MAO inhibitor
0,104  0,004  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,114  0,015  Aldose reductase inhibitor
0,116  0,018  GABA aminotransferase inhibitor
0,183  0,086  I kappa B kinase epsilon inhibitor
0,150  0,053  Pregnane X receptor agonist
0,170  0,074  Mcl-1 antagonist
0,119  0,024  Tocolytic
0,129  0,034  Alpha 1 adrenoreceptor antagonist
0,108  0,013  CDC25B inhibitor
0,146  0,052  Antihyperlipoproteinemic
0,128  0,035  Sphingomyelinase inhibitor
0,177  0,084  Platelet adhesion inhibitor
0,191  0,098  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,140  0,048  Interleukin 1b antagonist
0,097  0,006  Calcium channel P-type blocker
0,126  0,036  HIV-1 integrase (Overall Integration) inhibitor
0,114  0,026  Glutamate release inhibitor
0,201  0,113  Antiviral (West Nile virus)
0,116  0,028  Dopamine D2 antagonist
0,226  0,140  CYP3A4 inhibitor
0,094  0,008  5 Hydroxytryptamine 7 agonist
0,165  0,079  Phospholipase C inhibitor
0,179  0,093  Psychostimulant
0,136  0,050  Papain-like protease (SARS coronavirus) inhibitor
0,103  0,017  Alcohol oxidase inhibitor
0,154  0,070  Antiviral (Influenza A)
0,097  0,012  Glutamate (mGluR7) antagonist
0,088  0,003  Dopamine D1 agonist
0,118  0,034  Phosphodiesterase IV inhibitor
0,151  0,067  Hemostatic
0,144  0,060  Cyclooxygenase 1 inhibitor
0,107  0,023  Thioredoxin reductase inhibitor
0,092  0,009  Transcription factor RelA inhibitor
0,121  0,039  GABA C receptor rho-1 antagonist
0,190  0,108  Aryl hydrocarbon receptor agonist
0,108  0,026  Glycine receptor antagonist
0,097  0,016  5 Hydroxytryptamine 2A agonist
0,097  0,016  Alpha 2 adrenoreceptor agonist
0,095  0,016  Beta 3 adrenoreceptor antagonist
0,133  0,054  Antiviral (Papilloma)
0,123  0,044  Carbonic anhydrase XV inhibitor
0,113  0,035  Paget's disease treatment
0,114  0,037  Androgen antagonist
0,121  0,044  Antiprotozoal (Toxoplasma)
0,141  0,065  Antieczematic
0,094  0,019  Beta adrenoreceptor antagonist
0,212  0,137  CYP2D6 inhibitor
0,179  0,104  Antiviral (Ebola)
0,141  0,068  CNS active muscle relaxant
0,155  0,082  Interleukin 6 antagonist
0,124  0,050  Chelator
0,081  0,008  Ryanodine receptor antagonist
0,113  0,041  Antineoplastic antibiotic
0,092  0,019  Protein kinase C eta inhibitor
0,134  0,062  Antibacterial (Helicobacter pylori)
0,207  0,135  Antiischemic
0,092  0,021  MAP kinase kinase 7 inhibitor
0,090  0,019  Alpha 1 adrenoreceptor agonist
0,089  0,019  Androgen agonist
0,117  0,048  Urease inhibitor
0,134  0,065  Alpha-N-acetylglucosaminidase inhibitor
0,144  0,075  MAP kinase kinase 4 inhibitor
0,115  0,047  GST T1-1 substrate
0,101  0,034  Opioid kappa receptor antagonist
0,142  0,075  Antiprotozoal (Coccidial)
0,092  0,026  Glycine receptor agonist
0,118  0,053  Antihelmintic (Fasciola)
0,193  0,127  Interleukin agonist
0,134  0,068  Toll-Like receptor antagonist
0,077  0,012  Glucose-6-phosphate translocase inhibitor
0,170  0,106  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,099  0,036  Alpha 1b adrenoreceptor antagonist
0,084  0,021  5 Hydroxytryptamine 5A antagonist
0,172  0,109  Antiparasitic
0,100  0,037  Adrenaline agonist
0,108  0,045  Glutamate (mGluR7) agonist
0,092  0,030  Leukotriene synthesis inhibitor
0,114  0,054  GABA C receptor agonist
0,097  0,037  Alpha 1a adrenoreceptor antagonist
0,137  0,077  Protein kinase C nu inhibitor
0,095  0,036  D-Ala-D-Ala ligase inhibitor
0,116  0,057  GABA C receptor antagonist
0,144  0,086  Aldose reductase substrate
0,130  0,073  Cocaine dependence treatment
0,082  0,025  Uterine relaxant
0,101  0,044  Antidote, mercury
0,112  0,056  Mediator release inhibitor
0,115  0,059  Myasthenia Gravis treatment
0,063  0,007  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,077  0,022  5 Hydroxytryptamine 5 antagonist
0,149  0,094  Male reproductive disfunction treatment
0,085  0,030  Dopamine D3 antagonist
0,172  0,117  Dyrk kinase inhibitor
0,098  0,043  ATPase (Vacuolar H+) inhibitor
0,083  0,028  Endocannabinoid uptake inhibitor
0,108  0,054  Antifungal (Aspergillus)
0,181  0,127  Myocardial infarction treatment
0,099  0,046  Phosphodiesterase I inhibitor
0,074  0,022  Beta 1 adrenoreceptor antagonist
0,098  0,046  NADH dehydrogenase inhibitor
0,078  0,028  Exportin-1 inhibitor
0,068  0,018  Beta 2 adrenoreceptor antagonist
0,088  0,037  Glutamate decarboxylase inhibitor
0,133  0,082  Activin receptor-like kinase 2 inhibitor
0,121  0,070  Aldehyde dehydrogenase inhibitor
0,115  0,065  TRPA1 agonist
0,115  0,066  5 Hydroxytryptamine 2B antagonist
0,108  0,059  Antiinfertility, female
0,090  0,041  Na+ K+ transporting ATPase inhibitor
0,090  0,042  Phosphodiesterase 3A inhibitor
0,076  0,028  Antidote, heavy metal
0,125  0,078  Anesthetic
0,117  0,070  Alcohol dehydrogenase substrate
0,074  0,028  Xanthine dehydrogenase inhibitor
0,116  0,070  Anesthetic local
0,055  0,009  Melatonin 2 agonist
0,087  0,043  Ca(v)3.1 blocker
0,076  0,034  Dopamine D4 antagonist
0,060  0,018  Factor III inhibitor
0,065  0,022  Carbonic anhydrase XIV inhibitor
0,097  0,055  Bile acid receptor antagonist
0,050  0,008  Melatonin receptor 1A agonist
0,081  0,039  GABA B receptor agonist
0,061  0,020  Squalene epoxidase inhibitor
0,047  0,006  Estrogen-related receptor beta antagonist
0,054  0,014  Alpha 1d adrenoreceptor agonist
0,092  0,051  Contraceptive male
0,114  0,073  Constipation treatment
0,126  0,086  Nav1.6 sodium channel blocker
0,061  0,022  Anesthetic inhalation
0,128  0,090  Cyclooxygenase inhibitor
0,109  0,071  Protein-tyrosine phosphatase 1B inhibitor
0,201  0,163  Antiallergic
0,063  0,025  Pregnane X receptor antagonist
0,092  0,055  Opioid antagonist
0,151  0,114  Antiarrhythmic
0,131  0,094  Acetylcholine M1 receptor antagonist
0,148  0,112  Antihelmintic
0,056  0,020  Adenylate cyclase 1 inhibitor
0,075  0,039  Protein kinase C beta inhibitor
0,173  0,137  Immunostimulant
0,139  0,104  Prostate disorders treatment
0,069  0,035  Alpha 1d adrenoreceptor antagonist
0,117  0,083  Cyclooxygenase 2 inhibitor
0,128  0,094  Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor
0,169  0,135  ErbB-1 antagonist
0,115  0,082  DNA repair enzyme inhibitor
0,074  0,041  Phosphodiesterase III inhibitor
0,131  0,098  Neuropeptide Y1 antagonist
0,125  0,092  Farnesoid X receptor antagonist
0,044  0,012  Melatonin agonist
0,176  0,144  Antiprotozoal (Trypanosoma)
0,045  0,013  Vanilloid 3 antagonist
0,105  0,074  Platelet activating factor antagonist
0,069  0,038  5 Hydroxytryptamine 7 antagonist
0,088  0,058  Ornithine decarboxylase inhibitor
0,055  0,025  Potassium channel Kv1.3 blocker
0,070  0,040  Glutamate (mGluR6) antagonist
0,080  0,051  Antidote, organophosphates
0,092  0,063  Antineoplastic, alkylator
0,085  0,057  Myeloperoxidase inhibitor
0,106  0,079  Adenylate cyclase inhibitor
0,094  0,067  UDP-glucose 4-epimerase inhibitor
0,065  0,038  Phosphodiesterase 1C inhibitor
0,107  0,081  Interleukin 8 antagonist
0,053  0,029  Glycine transporter 2 inhibitor
0,082  0,058  CC chemokine 5 receptor agonist
0,070  0,046  Purinergic P2X2 antagonist
0,070  0,046  5 Hydroxytryptamine 1A antagonist
0,108  0,085  Growth stimulant
0,055  0,031  Vanilloid 2 antagonist
0,063  0,040  Transcription factor AP-1 inhibitor
0,066  0,043  Opioid delta receptor antagonist
0,103  0,081  Antiviral (SARS coronavirus)
0,103  0,081  Antiviral (Coronavirus)
0,185  0,162  Antifungal
0,045  0,023  Liver X receptor alpha agonist
0,075  0,054  Antitreponemal
0,037  0,017  Melatonin 1 agonist
0,042  0,022  5 Hydroxytryptamine 2B agonist
0,045  0,026  Guanylate cyclase inhibitor
0,114  0,094  Alkaline phosphatase inhibitor
0,103  0,085  Aldehyde dehydrogenase substrate
0,067  0,049  Phenylalanine 4-hydroxylase inhibitor
0,036  0,018  Nucleoside transporters inhibitor
0,049  0,031  Antibiotic Glycopeptide-like
0,081  0,063  Antiviral (Trachoma)
0,122  0,105  Antianemic
0,023  0,006  NMDA receptor phencyclidine site antagonist
0,087  0,070  Antiviral (Hepatitis A)
0,096  0,080  5 Hydroxytryptamine 3A agonist
0,065  0,049  Opioid mu receptor antagonist
0,117  0,102  Antiischemic, cerebral
0,081  0,066  mTOR complex 2 inhibitor
0,078  0,064  Antispirochetal
0,041  0,028  Phenylethanolamine N methyltransferase inhibitor
0,085  0,072  Alcohol dehydrogenase inhibitor
0,089  0,076  Dementia treatment
0,134  0,121  Amyloid beta precursor protein antagonist
0,039  0,026  Vesicle monoamine transporter inhibitor
0,021  0,009  Antibiotic Anthracycline-like
0,086  0,075  Vascular dementia treatment
0,024  0,013  Estrone sulfatase inhibitor
0,220  0,210  DNA polymerase beta inhibitor
0,033  0,023  Estrogen-related receptor alpha antagonist
0,029  0,020  Liver X receptor alpha antagonist
0,060  0,050  Beta 2 adrenoreceptor agonist
0,056  0,046  Lipocortins synthesis agonist
0,038  0,029  Dopamine D3 agonist
0,032  0,024  Catechol O-methyltransferase inhibitor
0,048  0,040  5 Hydroxytryptamine 2 agonist
0,083  0,076  Thioredoxin inhibitor
0,056  0,049  Phosphodiesterase 1B inhibitor
0,076  0,069  Inducible nitric-oxide synthase inhibitor
0,028  0,021  Liver X receptor beta antagonist
0,050  0,044  Leukotriene B4 antagonist
0,030  0,024  ATP citrate lysase inhibitor
0,077  0,071  Histamine N-methyltransferase inhibitor
0,018  0,012  Antibiotic Trimethoprim-like
0,065  0,060  Catalase inhibitor
0,058  0,053  Heme oxygenase stimulant
0,057  0,052  Antimycoplasmal
0,016  0,012  Ileal bile acid transport inhibitor
0,039  0,035  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,047  0,044  CD45 antagonist
0,079  0,076  MAO B inhibitor
0,066  0,063  NAT1 substrate
0,041  0,039  Carbonic anhydrase VII inhibitor
0,055  0,053  NMDA 2C receptor antagonist
0,164  0,161  Age-related macular degeneration treatment
0,030  0,029  Sodium-dependent vitamin C transporter 2 inhibitor
0,024  0,023  Sodium/glucose cotransporter 2 inhibitor
0,072  0,071  Calcium antagonist
0,020  0,020  CYP24 inhibitor
0,040  0,040  Potassium channel small-conductance Ca-activated blocker
0,029  0,029  GABA transporter 3 inhibitor
0,008  0,008  Progesterone receptor A antagonist

